BNP Paribas Financial Markets
TSRX

BNP Paribas Financial Markets’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

BNP Paribas Financial Markets’s Portfolio TSRX Stock Details TSRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-13,272
Closed -$108K – 2867
2013
Q2 		$108K Buy
+13,272
New +$98K ﹤0.01% 2515

Other funds holding TSRX

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

BNP Paribas Financial Markets's TSRX Position: Q3 2013 in Review

BNP Paribas Financial Markets sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 13,272 shares — an estimated $108K sold.

BNP Paribas Financial Markets first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $108K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

  • BNP Paribas Financial Markets reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 13,272 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $108K.
  • BNP Paribas Financial Markets first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
  • BNP Paribas Financial Markets's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $108K in Q2 2013.
  • 7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2013, filed 13 Nov 2013.